SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES
Clinical trials for SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Proton beams take aim at inoperable sarcomas in new trial
Disease control Recruiting nowThis study tests whether a higher dose of proton radiation can better control soft tissue sarcomas that cannot be surgically removed. About 40 adults in Norway will receive radiation over 4 weeks, with the highest dose focused on the tumor center. Researchers will also look at bl…
Matched conditions: SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Glow-in-the-dark dye may help surgeons cut out sarcomas with cleaner edges
Disease control Recruiting nowThis study tests whether using a fluorescent dye called indocyanine green (ICG) during surgery helps surgeons see and remove sarcoma tumors more completely. About 90 adults with intermediate-to-high grade sarcoma of the trunk or limbs will take part. The goal is to reduce the num…
Matched conditions: SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES
Phase: NA • Sponsor: University of Aarhus • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New 3-Week radiation plan aims to cut side effects for sarcoma patients
Disease control Recruiting nowThis study tests whether a personalized, 3-week course of proton or x-ray radiation before surgery can reduce long-term side effects for adults with soft tissue sarcoma. About 110 participants will have two radiation plans made, and a national team will choose the best one for ea…
Matched conditions: SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
Sarcoma atlas aims to tailor chemo for 800 patients
Knowledge-focused Recruiting nowThis study looks at tissue and imaging data from 800 people with high-risk soft tissue sarcoma to find ways to personalize chemotherapy. Participants either have surgery alone or chemo before surgery. The goal is to build a tumor atlas and a tool to predict who benefits from chem…
Matched conditions: SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 17, 2026 00:53 UTC